These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7187165)
1. [Pharmacology of vasodilator drugs; recent developments]. van Zwieten PA; van Meel JC; de Jonge A; Kalkman HO; Timmermans PB Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():78-86. PubMed ID: 7187165 [No Abstract] [Full Text] [Related]
2. Concepts of peripheral circulatory control: implications for vasodilator therapy in heart failure. Rubin SA; Swan HJ Cardiovasc Clin; 1984; 14(3):19-29. PubMed ID: 6144389 [No Abstract] [Full Text] [Related]
3. [Therapy of chronic heart failure with vasodilator agents]. Zähringer J; Schultheiss HP Internist (Berl); 1986 May; 27(5):315-21. PubMed ID: 3015822 [No Abstract] [Full Text] [Related]
4. [Clinical experiences and value of vasodilation in myocardial insufficiency]. Just H Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():87-97. PubMed ID: 7187166 [No Abstract] [Full Text] [Related]
5. [Use of vasodilators in treating cardiac insufficiency]. Malamov E Vutr Boles; 1980; 19(5):10-5. PubMed ID: 7003916 [No Abstract] [Full Text] [Related]
6. Vasodilator therapy in cardiac failure what was new is old. O'Rourke MF; Nichols WW J Am Coll Cardiol; 2009 Mar; 53(10):898; discussion 898-99. PubMed ID: 19264253 [No Abstract] [Full Text] [Related]
7. Vasodilator agents in chronic heart failure. Chatterjee K Dan Med Bull; 1983 Apr; 30 Suppl 1():1-9. PubMed ID: 6345096 [No Abstract] [Full Text] [Related]
8. Recent advances in vasodilator therapy. Part I: physiologic correlations. Aranda JM; Linares E; Hernández-López E; Cintrón G; Song S Bol Asoc Med P R; 1981 Jan; 73(1):3-10. PubMed ID: 7020713 [No Abstract] [Full Text] [Related]
9. Pathophysiological considerations in selecting vasodilator therapy for CHF. Cohn JN Acta Med Scand Suppl; 1981; 652():93-7. PubMed ID: 6949468 [No Abstract] [Full Text] [Related]
10. [Therapy of early and manifest heart failure with vasodilator agents]. Just H; Drexler H; Meinertz T Verh Dtsch Ges Inn Med; 1985; 91():139-43. PubMed ID: 4090611 [No Abstract] [Full Text] [Related]
17. [Treatment of cardiac insufficiency with systemic vasodilator agents]. García Puig J; Gil Aguado A; Arnalich F; Gaspar G; Anciones B; Vázquez JJ Med Clin (Barc); 1980 Nov; 75(9):398-403. PubMed ID: 7464335 [No Abstract] [Full Text] [Related]
18. [Effects of vasodilators on resting and exercise hemodynamics in patients with chronic congestive heart failure (author's transl)]. Higaki S; Tomiya H; Makita K; Fukuda T; Nakamura Y Kokyu To Junkan; 1981 Jun; 29(6):647-58. PubMed ID: 7313365 [No Abstract] [Full Text] [Related]
19. The flosequinan experience and its implications. Hingorani AD Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):683; author reply 683-4. PubMed ID: 8124556 [No Abstract] [Full Text] [Related]